Patents by Inventor Richard Tester
Richard Tester has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Patent number: 8507462Abstract: Methods of controlling serum glucose levels in an individual are described, the methods including the step of administering to said individual a therapeutic food composition comprising a waxy and/or hydrothermally treated starch. The method may be used to treat or prevent hypoglycaemia in patients susceptible to hypoglycaemic episodes, for example patients with glycogen storage disease, diabetes or liver disease. The method may also be used in sports nutrition. Also described are compositions for use in the methods.Type: GrantFiled: November 8, 2004Date of Patent: August 13, 2013Assignee: Glycologic LimitedInventors: Xin Qi, Richard Tester
-
Patent number: 8137706Abstract: Carbohydrates, in particular mannose containing carbohydrates, are used as a promotor of cell growth. Specifically, polysaccharide hydrolysates are shown to have superior efficacy in promoting the growth of cells, synbiotic foods, prebiotics and pharmaceutical compositions containing mannose containing carbohydrates and polysaccharide hydrolysates described.Type: GrantFiled: May 16, 2005Date of Patent: March 20, 2012Assignee: Glycologic LimitedInventors: Farage Al-Ghazzewi, Richard Tester
-
Publication number: 20090275530Abstract: Provided are methods of inducing satiety in an individual using gastric raft compositions and compositions suitable for such methods. The gastric raft compositions may comprise processed starches such as dextrins. Also described are methods of treating diseases characterised by hypoglycaemia, such as glycogen storage disease (GSD), and diabetes.Type: ApplicationFiled: March 16, 2006Publication date: November 5, 2009Applicant: GLYCOLOGIC LIMITEDInventors: Richard Tester, Denise Hooper
-
Patent number: 7488744Abstract: The invention is directed to methods to inhibit p38-? kinase using compounds comprising a phenyl or thienyl coupled through a piperidine or piperazine nucleus to an indole residue wherein the indole residue mandatorily has a substituent on the ring nitrogen which is an amino or substituted amino group.Type: GrantFiled: May 22, 2007Date of Patent: February 10, 2009Assignee: Scios, Inc.Inventors: Sarvajit Chakravarty, Sundeep Dugar, Qing Lu, Gregory R. Luedtke, Babu J. Mavunkel, John J. Perumattam, Richard Tester
-
Publication number: 20080226603Abstract: Carbohydrates, in particular mannose containing carbohydrates, are used as a promotor of cell growth. Specifically, polysaccharide hydrolysates are shown to have superior efficacy in promoting the growth of cells, synbiotic foods, prebiotics and pharmaceutical compositions containing mannose containing carbohydrates and polysaccharide hydrolysates described.Type: ApplicationFiled: May 16, 2005Publication date: September 18, 2008Inventors: Farage Al-Ghazzewi, Richard Tester
-
Patent number: 7360946Abstract: A thermal history indicator comprising a temperature sensitive material, a sensing device, a heat insulating material functioning to buffer the temperature sensitive material against temperature change, and an activation means. The triggering of the activation means allows a molten phase of the temperature sensitive material to interact with the sensing device, or cease interacting with the sensing device, thereby altering its chemical, biochemical or microbiological.Type: GrantFiled: July 8, 2002Date of Patent: April 22, 2008Assignee: Temp-Tell LimitedInventors: Richard Tester, Farage Al-Ghazzewi
-
Publication number: 20070232617Abstract: The invention is directed to methods to inhibit p38-? kinase using compounds comprising a phenyl or thienyl coupled through a piperidine or piperazine nucleus to an indole residue wherein the indole residue mandatorily has a substituent on the ring nitrogen which is an amino or substituted amino group.Type: ApplicationFiled: May 22, 2007Publication date: October 4, 2007Applicant: Scios, Inc.Inventors: Sarvajit Chakravarty, Sundeep Dugar, Qing Lu, Gregory Luedtke, Babu Mavunkel, John Perumattam, Richard Tester
-
Publication number: 20070077277Abstract: Methods of controlling serum glucose levels in an individual are described, the methods including the step of administering to said individual a therapeutic food composition comprising a waxy and/or hydrothermally treated starch. The method may be used to treat or prevent hypoglycaemia in patients susceptible to hypoglycaemic episodes, for example patients with glycogen storage disease, diabetes or liver disease. The method may also be used in sports nutrition. Also described are compositions for use in the methods.Type: ApplicationFiled: November 8, 2004Publication date: April 5, 2007Applicant: GLYCOLOGIC LIMITEDInventors: Xin Qi, Richard Tester
-
Publication number: 20060199821Abstract: The invention is directed to compounds and methods to inhibit p38 kinase wherein the compounds are a pyrimidine or pyridine coupled to two mandatory substituents.Type: ApplicationFiled: August 3, 2005Publication date: September 7, 2006Applicant: Scios, Inc.Inventors: Richard Tester, Xuefei Tan, Kurt Schinzel, Imad Nashashibi, Gregory Luedtke, Weiling Liang, Joon Jung, R. Goehring, Sundeep Dugar, Steven Do
-
Publication number: 20060134006Abstract: A formulation, especially a pharmaceutical formulation, comprises an active agent and a carrier for the active agent, wherein the carrier comprises a beta-limit dextrin. The formulation may be a bioadhesive pharmaceutical formulation in which the beta-limit dextrin acts as a mucoadhesive agent. The active agent is a pharmaceutically active agent or a flavour or fragrance which is intended for delivery into the buccal cavity. A use of beta-limit dextrin as a disintegrant, a dispersant, and a mucoadhesive agent is also described. Also described is a nutritional product such as an energy drink which includes beta-limit dextrin as an energy source.Type: ApplicationFiled: July 29, 2003Publication date: June 22, 2006Applicant: Glycologic LimitedInventors: Richard Tester, Xin Qi
-
Patent number: 7036452Abstract: A temperature history indicator means for affixing to goods. A temperature related phase change in a material within the indicator leads to an indication that a high temperature event has occurred. A preferred format has a water-soluble, lipid-insoluble dye immobilised within a lipid selected to have a melting point at a particular temperature and has all components made from edible materials. Upon melting, the dye dissolves in water present in a secondary phase or the goods themselves giving a visual indication. Another format has a primary reagent within a solid lipid and a secondary reagent held with a secondary phase such that melting of the lipid allows the primary reagent to react with the secondary reagent, providing an indication of a high temperature event. Time-dependent formats are also considered.Type: GrantFiled: February 10, 2000Date of Patent: May 2, 2006Assignee: Temp-Tell LimitedInventor: Richard Tester
-
Publication number: 20040233967Abstract: A thermal history indicator comprising a temperature sensitive material, a sensing device, a heat insulating material functioning to buffer the temperature sensitive material against temperature change, and an activation means. The triggering of the activation means allows a molten phase of the temperature sensitive material to interact with the sensing device, or cease interacting with the sensing device, thereby altering its chemical, biochemical or microbiological.Type: ApplicationFiled: June 23, 2004Publication date: November 25, 2004Inventor: Richard Tester